Copper peptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-02-21. Anything still debated is marked as such rather than presented as settled.
Analytical confirmation usually combines a separation method with a copper-specific measurement. Liquid chromatography or mass spectrometry establishes peptide identity and purity, while an elemental measurement quantifies the metal content. A frequent misconception is that any blue solution contains an intact copper peptide complex; color alone does not confirm structure, because free copper salts and degraded mixtures can also appear colored. Literature on efficacy is mixed, with in vitro findings often more dramatic than human evidence, and reviews note small sample sizes and short follow-up. Open questions include optimal concentration, skin penetration, and long-term effects.
Proposed mechanisms for copper peptide activity center on delivery of copper ions to cells and on peptide fragments acting as signaling molecules. Copper is a cofactor for enzymes involved in collagen cross-linking and antioxidant defense, and the peptide may improve its availability at target sites. Separately, the tripeptide and its breakdown products have been reported to influence gene expression in cultured fibroblasts. Much of this evidence comes from laboratory cell cultures and animal models rather than controlled human trials. The relative contribution of the copper ion and the peptide sequence is therefore not fully settled.
The International Nomenclature of Cosmetic Ingredients lists the substance as copper tripeptide-1, the name that appears on most topical product labels. Related designations include copper peptide and GHK-Cu, and the hyphenated form is common in research literature. In cosmetics the material is regulated as an ingredient rather than as a drug, so products may reach the market without evidence of the effects claimed for them. Whether those effects are clinically meaningful is an open question, since most supportive data come from laboratory work and small trials.
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence found naturally in human plasma, saliva and urine. Loren Pickart reported the isolation of the free peptide in 1973 while studying factors that influenced the growth of aged liver cells in culture. The peptide was later shown to bind copper(II) with high affinity, and the metal-bound form became the focus of most subsequent research. Its concentration in circulation declines markedly with age, a pattern that is well documented, though the physiological consequences of that decline remain debated.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C | Dry, protected from light |
| Appearance in solution | Blue | Tone varies with pH and concentration |
| Primary analytical method | LC-MS with ICP-MS | Identity plus copper content |
| pH sensitivity | Higher near neutral and above | Alkaline conditions can degrade it |
| Common supplied form | Freeze-dried solid | Dissolved before use |
Analytical verification commonly relies on high-performance liquid chromatography for purity assessment and mass spectrometry for identity confirmation. Spectroscopic methods such as UV-visible absorption and electron paramagnetic resonance can probe the metal centre itself, since the d9 configuration of copper(II) produces characteristic signals. Elemental analysis or plasma-based techniques quantify copper content. Because each method reports a different aspect of the same sample, purity figures are most meaningful when the technique and its detection wavelength are stated alongside the value.
Stability of the complex in solution depends on pH, temperature, and the presence of competing ligands. It is generally described as more resistant to breakdown than the metal-free chain, since coordination reduces susceptibility to enzymatic attack. Oxidation and hydrolysis can nevertheless proceed over time in aqueous media. Storage guidance in laboratory settings commonly involves refrigeration, protection from light, and avoidance of strongly alkaline conditions. Published data on long-term behaviour vary considerably and depend on the specific matrix.
Handling practices for the solid material emphasise low temperature and dryness. The lyophilised or powdered form is typically kept at refrigerator or freezer temperatures together with a desiccant. Working solutions are often prepared fresh, because repeated freeze-thaw cycles and extended storage may alter the complex. Glass or inert plastic containers are preferred over materials that could leach metal ions into the preparation. Such practices follow general peptide conventions rather than substance-specific regulations.
Discovery of GHK is generally attributed to work in the 1970s that isolated a plasma factor influencing liver cell behavior. Subsequent studies identified the copper-binding tripeptide and its ability to chelate copper with high affinity. Early reports linked the complex to wound healing and tissue remodeling in animal models. The free peptide and the copper-bound form have different properties, so the two are distinguished in the literature. Whether endogenous GHK-Cu serves a single primary physiological role remains an open question.
The molecular weight and charge of GHK-Cu depend on the pH and the number of coordinated ligands. At neutral pH, the peptide typically binds one copper ion, but ternary complexes with other biomolecules can form. Spectroscopic methods such as electron paramagnetic resonance and circular dichroism are used to study the coordination environment. Reports on the exact geometry vary because the complex is dynamic in solution. Researchers often use synthetic GHK-Cu rather than extracted material to control stoichiometry and purity.
GHK-Cu is a coordination complex formed from the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide binds copper through its histidine imidazole nitrogen, the terminal amino group, and the deprotonated amide nitrogen. This arrangement creates a square-planar or distorted geometry around the metal center, depending on pH and the presence of competing ligands. The complex occurs naturally in human plasma, saliva, and urine at low concentrations, and its sequence is conserved across many vertebrate species.
The compound was first isolated from human plasma in the 1970s by Loren Pickart, who later described copper-binding activity in liver and other tissues. Early reports focused on its presence in blood and its ability to carry copper between proteins. Commercial and cosmetic use of the term 'copper peptide' has since broadened, and labels rarely distinguish GHK-Cu from other copper-binding fragments. This naming overlap makes literature searching harder, because cosmetic ingredient lists, supplier catalogues and laboratory papers use different vocabularies for the same molecule.
GHK-Cu is the copper-binding complex formed by the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The free peptide is usually written as GHK, and the complex is written as GHK-Cu or Cu-GHK. The sequence was identified in human plasma and later detected in saliva and urine. Its name comes from the single-letter codes of glycine, histidine and lysine. The complex is widely described as a naturally occurring carrier of copper in blood rather than as a free peptide with its own hormonal role.
Identity and purity are established with a combination of chromatographic and spectroscopic techniques. Reversed-phase high-performance liquid chromatography separates the intact complex from peptide fragments and free copper, and the elution profile yields a purity estimate. Mass spectrometry gives the mass of the intact species and exposes degradation products. Ultraviolet-visible spectroscopy displays a broad absorption band in the visible region that is characteristic of the copper center. Nuclear magnetic resonance is less informative here, because the paramagnetic metal broadens signals and complicates spectral interpretation.
Copper content is measured separately, since a peptide assay alone does not report the metal-to-peptide ratio. Elemental techniques such as inductively coupled plasma optical emission spectroscopy quantify copper after acid digestion of the sample. The result is compared with the theoretical value for a one-to-one complex, and a shortfall indicates free peptide or partial dissociation. Suppliers differ in how they state purity, as some quote peptide content and others quote the whole complex. A defined stoichiometry therefore requires both a peptide assay and a copper assay.
Enzymnamen haben die Endung (oder das Suffix) „-ase“, wenn das betreffende Enzym chemische oder organische Verbindungen auftrennt oder spaltet (wie beispielsweise die „Hydrolasen“ oder „Proteasen“) oder neuverbindet (wie beispielsweise die „Oxidasen“ oder „Telomerase“). Der Enzymname soll erklärend sein, also die Reaktion, die das Enzym katalysiert, beschreiben. (Beispiel: Cholinesterase: Ein Enzym, das die Estergruppe im Cholin-Molekül hydrolysiert.) Der Enzymname soll seine Klassifikation (siehe unten) enthalten. (Beispiel: Cholinesterase) Außerdem wurde ein Codesystem, das EC-Nummern-System, entwickelt, in dem die Enzyme unter einem Zahlencode aus vier Zahlen eingeteilt werden. Die erste Zahl bezeichnet eine der sieben Enzymklassen. Listen aller erfassten Enzyme gewährleisten ein schnelleres Auffinden des angegebenen Enzymcodes, z. B. bei BRENDA. Zwar orientieren sich die Codes an Eigenschaften der Reaktion, die das Enzym katalysiert, in der Praxis erweisen sich Zahlencodes jedoch als unhandlich. Häufiger gebraucht werden systematische, nach den oben genannten Regeln konzipierte Namen. Probleme der Nomenklatur ergeben sich etwa bei Enzymen, die mehrere Reaktionen katalysieren. Für sie existieren deshalb manchmal mehrere Namen. Einige Enzyme tragen Trivialnamen, die nicht erkennen lassen, dass es sich bei der genannten Substanz um Enzyme handelt. Da die Namen traditionell eine breite Verwendung fanden, wurden sie teilweise beibehalten (Beispiele: die Verdauungsenzyme Trypsin und Pepsin des Menschen).
EC 1: Oxidoreduktasen, die Redoxreaktionen katalysieren. EC 2: Transferasen, die funktionelle Gruppen von einem Substrat auf ein anderes übertragen. EC 3: Hydrolasen, die Bindungen unter Einsatz von Wasser spalten. EC 4: Lyasen, die die Spaltung oder Synthese komplexerer Produkte aus einfachen Substraten katalysieren, allerdings ohne Verbrauch von Adenosintriphosphat (ATP) oder eines anderen Nukleosidtriphosphats (NTP). EC 5: Isomerasen, die die Umwandlung von chemischen Isomeren beschleunigen. EC 6: Ligasen oder Synthetasen, die Additionsreaktionen mithilfe von ATP (oder eines anderen NTP) katalysieren. Eine Umkehrreaktion (Spaltung) ist meist energetisch ungünstig und findet nicht statt. EC 7: Translokasen, die den Transport von Stoffen an oder durch Zellmembranen katalysieren. Manche Enzyme sind in der Lage, mehrere, zum Teil sehr unterschiedliche Reaktionen zu katalysieren. Ist dies der Fall, werden sie mehreren Enzymklassen zugerechnet.
== Aufbau == Enzyme lassen sich anhand ihres Aufbaus unterscheiden. Während viele Enzyme aus nur einer Polypeptidkette bestehen, so genannte Monomere, bestehen andere Enzyme, die Oligomere, aus mehreren Untereinheiten/Proteinketten. Einige Enzyme lagern sich mit weiteren Enzymen zu sogenannten Multienzymkomplexen zusammen und kooperieren oder regulieren sich gegenseitig. Umgekehrt gibt es auch einzelne Proteinketten, welche mehrere, verschiedene Enzymaktivitäten ausüben können (multifunktionelle Enzyme). Eine weitere mögliche Einteilung hinsichtlich ihres Aufbaus berücksichtigt das Vorhandensein von Kofaktoren:
Reine Protein-Enzyme bestehen ausschließlich aus Proteinen und verarbeiten Substrate schneller als Holoenzyme. Das aktive Zentrum wird nur aus Aminosäureresten und dem Peptidrückgrat gebildet. Zu dieser Gruppe gehören beispielsweise das Verdauungsenzym Chymotrypsin und die Triosephosphatisomerase (TIM) der Glykolyse. Holoenzyme (altgr. ὅλος holos „ganz“, „vollständig“ und -enzym) bestehen aus einem Proteinanteil, dem Apoenzym, sowie aus einem Kofaktor, einem niedermolekularen Molekül (kein Protein). Beide zusammen sind für die Funktion des Enzyms wichtig. Organische Moleküle als Kofaktoren werden Koenzyme genannt. Sind sie kovalent an das Apoenzym gebunden, nennt man sie prosthetische Gruppen, andernfalls zutreffender Kosubstrat, da sie in äquivalenten Mengen bei der enzymatischen Reaktion mit dem Substrat umgesetzt werden. Kosubstrate sind zum Beispiel Adenosintriphosphat (ATP) und Nicotinamidadenindinukleotid (NAD). ATP wird oft als Energiequelle für die Reaktion von Proteinkinasen genutzt. NAD wird von Enzymen, wie der Alkoholdehydrogenase, als Elektronenakzeptor verwendet. Benötigt ein Enzym Metallionen (Eisen-, Zink- oder Kupferionen), spricht man von einem Metalloenzym. Die Lipoxygenase zum Beispiel enthält Eisen und die Carboanhydrase enthält Zink. Eine spezielle Gruppe bilden die Protein-RNA-Komplexe bzw. Protein-Ribozym-Komplexe, Beispiele hierfür sind die Telomerasen. Auch die Ribosomen sind solche Komplexe.
Sources: de.wikipedia.org
Freezer temperatures are common for long-term retention. Light and moisture exposure should be limited. Working portions are best kept cold and used without repeated freeze-thaw cycles.
Sequence assays confirm the amino acids but say nothing about the metal. Copper content links the peptide to the ion that defines the complex. An elemental technique is used for this step.
No. Several copper species and degraded mixtures can also look blue. Confirmation needs both separation data and elemental data.
It is a complex of a three-amino-acid peptide, glycine, histidine and lysine, bound to a single copper(II) ion. The metal is held mainly by the histidine side chain and the peptide backbone. Most commercial material is supplied as an acetate salt rather than as the free complex.